alendronate has been researched along with cyclic gmp in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aragão, KS; Barbosa, AL; Junior, EM; Lucetti, LT; Medeiros, JV; Ribeiro, RA; Silva, RO; Soares, PM; Souza, MH; Wong, DV | 1 |
1 other study(ies) available for alendronate and cyclic gmp
Article | Year |
---|---|
Alendronate induces gastric damage by reducing nitric oxide synthase expression and NO/cGMP/K(ATP) signaling pathway.
Topics: Administration, Oral; Alendronate; Animals; Cyclic GMP; Dose-Response Relationship, Drug; Female; KATP Channels; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Signal Transduction; Stomach Ulcer; Structure-Activity Relationship | 2014 |